Leaflet STOPTUSSIN 1.5mg / ml syrup

Product code:
W71710001
Quantity:
1
Indicated for:
dry cough
Route of administration:
oral
Substance:
butamirat (expectorant)
ATC
R05DB13 — Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants
Butamirate is a medication used for the treatment of dry, non-productive cough. It acts as a central antitussive, inhibiting the cough reflex at the central nervous system level without causing dependency.

The medication is taken orally, in the form of syrup or tablets, as directed by a doctor. The dosage is adjusted based on the patient's age and weight.

Common side effects include drowsiness, dizziness, and nausea. In rare cases, allergic reactions such as skin rashes or breathing difficulties may occur.

Butamirate is not recommended for pregnant women during the first trimester or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other medications being used to avoid drug interactions.

General data about STOPTUSSIN 1.5mg / ml

Substance:
butamirat
Date of latest medicines list:
01-03-2026
Product code:
W71710001
Concentration:
1.5mg / ml
Pharmaceutical form:
syrup
Quantity:
1
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
BALKAN PHARMA TROYAN AD - BULGARIA
Holder:
TEVA B.V. - TARILE DE JOS
Number:
16403/2026/01
Shelf life:
2 years-after packaging for sale;after the first opening of the bottle-6 months

Pharmaceutical forms available for butamirat

Concentrations available for butamirat

  • 1.5mg/ml
  • 5mg/ml
  • 7.5mg/5ml